CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $177,048
- in 4 filings
Net −$177,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-20 | French Glendon E. III Director | Sale 10b5-1 | −43,036 | $8.14 | $350K | 1,024,391 |
| 2025-02-20 | French Glendon E. III Director | Sale 10b5-1 | −12,417 | $8.76 | $109K | 1,011,974 |
| 2025-01-17 | French Glendon E. III Director | Sale 10b5-1 | −2,221 | $6.50 | $14K | 1,067,427 |
| 2025-01-16 | French Glendon E. III Director | Sale 10b5-1 | −2,326 | $6.53 | $15K | 1,069,648 |
| 2024-12-02 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −392 | $6.19 | $2K | 295,041 |
| 2024-12-02 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −690 | $6.18 | $4K | 294,351 |
| 2024-12-02 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −1,756 | $6.19 | $11K | 292,595 |
| 2024-12-02 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −1,538 | $6.18 | $10K | 291,057 |
| 2024-12-02 | Lehman David Aaron GENERAL COUNSEL | Sale | −410 | $6.18 | $3K | 202,938 |
| 2024-12-02 | Lehman David Aaron GENERAL COUNSEL | Sale | −722 | $6.19 | $4K | 202,216 |
| 2024-12-02 | Lehman David Aaron GENERAL COUNSEL | Sale | −2,755 | $6.19 | $17K | 199,461 |
| 2024-12-02 | Lehman David Aaron GENERAL COUNSEL | Sale | −1,610 | $6.18 | $10K | 197,851 |
| 2024-11-22 | French Glendon E. III Director | Sale 10b5-1 | −20,000 | $6.63 | $133K | 1,071,974 |
| 2024-10-17 | French Glendon E. III Director | Sale 10b5-1 | −20,000 | $6.52 | $130K | 1,091,974 |
| 2024-09-12 | French Glendon E. III Director | Sale 10b5-1 | −20,000 | $8.09 | $162K | 1,111,974 |
| 2024-09-03 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −410 | $6.71 | $3K | 299,609 |
| 2024-09-03 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −724 | $6.69 | $5K | 298,885 |
| 2024-09-03 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −1,842 | $6.69 | $12K | 297,043 |
| 2024-09-03 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale | −1,610 | $6.71 | $11K | 295,433 |
| 2024-09-03 | Lehman David Aaron GENERAL COUNSEL | Sale | −429 | $6.71 | $3K | 208,684 |
Page 7 of 12 · 235 trades